PDX-1 (Pancreatic/Duodenal Homeobox-1 Protein 1)

Pathologica

Volumn 106, Issue 4, 2014, Pages 315-321

  Pedica, F ^a,b   Beccari, S ^b   Pedron, S ^b   Montagna, L ^b   Piccoli, P ^b   Doglioni, C ^a   Chilosi, M ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Immunoistochemistry; Normal human tissues; Pancreatic development; Pdx 1

Indexed keywords

DNA BINDING PROTEIN; HOMEODOMAIN PROTEIN; PANCREATIC AND DUODENAL HOMEOBOX 1 PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL; DIABETES COMPLICATIONS; HOMEOBOX; HUMAN; METABOLISM; PANCREAS ISLET; PANCREATIC NEOPLASMS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; DIABETES COMPLICATIONS; DNA-BINDING PROTEINS; GENES, HOMEOBOX; HOMEODOMAIN PROTEINS; HUMANS; ISLETS OF LANGERHANS; PANCREATIC NEOPLASMS; TRANS-ACTIVATORS;

EID: 84929515640     PISSN: 00312983     EISSN: 1591951X     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Gu G, Dubauskaite J, Melton DA. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 2002;129:2447-57.
2. Brooke NM, Garcia-Fernandez J, Holland PW. The ParaHox gene cluster is an evolutionary sister of the Hox gene cluster. Nature 1998;392:920-2.
3. Sharma S, Leonard J, Lee S, et al. Pancreatic islet expression of the homeobox factor STF-1 relies on an E-box motif that binds USF. J Biol Chem 1996;271:2294-9.
4. Yokoi N, Serikawa T, Walther R. Pdx-1, a homeodomain transcription factor required for pancreas development, maps to rat chromosome 12. Exp Anim 1997;46:323-4.
5. Ohlsson H, Karlsson K, Edlund T. IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO J 1993;12:4251-9.
6. Leonard J, Peers B, Johnson T, et al. Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells. Mol Endocrinol 1993;7:1275-83.
7. Jonsson J, Carlsson L, Edlund T, et al. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994;371:606-9.
8. Stoffel M, Stein R, Wright CV, et al. Localization of human homeodomain transcription factor insulin promoter factor 1 (IPF1) to chromosome band 13q12.1. Genomics 1995;28:125-6.
9. Marshak S, Benshushan E, Shoshkes M, et al. Functional conservation of regulatory elements in the pdx-1 gene: PDX-1 and hepatocyte nuclear factor 3beta transcription factors mediate betacell- specific expression. Mol Cell Biol 2000;20:7583-90.
10. Asahara H, Dutta S, Kao HY, et al. Pbx-Hox heterodimers recruit coactivator-corepressor complexes in an isoform-specific manner. Mol Cell Biol 1999;19:8219-25.
11. Docherty K, Clark AR. Nutrient regulation of insulin gene expression. FASEB J 1994;8:20-7.
12. Serup P, Jensen J, Andersen FG, et al. Induction of insulin and islet amyloid polypeptide production in pancreatic islet glucagonoma cells by insulin promoter factor 1. Proc Natl Acad Sci U S A 1996;93:9015-20.
13. Waeber G, Thompson N, Nicod P, et al. Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. Mol Endocrinol 1996;10:1327-34.
14. Watada H, Kajimoto Y, Umayahara Y, et al. The human glucokinase gene beta-cell-type promoter: an essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells. Diabetes 1996;45:1478-88.
15. Fujitani Y, Fujitani S, Boyer DF, et al. Targeted deletion of a cisregulatory region reveals differential gene dosage requirements for Pdx-1 in foregut organ differentiation and pancreas formation. Genes Dev 2006;20:253-66.
16. Petersen HV, Peshavaria M, Pedersen AA, et al. Glucose stimulates the activation domain potential of the PDX-1 homeodomain transcription factor. FEBS Lett 1998;431:362-6.
17. Rafiq I, Kennedy HJ, Rutter GA. Glucose-dependent translocation of insulin promoter factor-1 (IPF-1) between the nuclear periphery and the nucleoplasm of single MIN6 beta-cells. J Biol Chem 1998;273:23241-7.
18. Slack JM. Developmental biology of the pancreas. Development 1995;121:1569-80.
19. Offield MF, Jetton TL, Labosky PA, et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 1996;122:983-95.
20. Larsson LI, Madsen OD, Serup P, et al. Pancreatic-duodenal homeobox 1 -role in gastric endocrine patterning. Mech Dev 1996;60:175-84.
21. Guz Y, Montminy MR, Stein R, et al. Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development 1995;121:11-8.
22. Melloul D, Marshak S, Cerasi E. Regulation of pdx-1 gene expression. Diabetes 2002;51 Suppl 3:S320-S5.
23. Golosow N, Grobstein C. Epitheliomesenchymal interaction in pancreatic morphogenesis. Dev Biol 1962;4:242-55.
24. Ahlgren U, Jonsson J, Edlund H. The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/PDX-1-deficient mice. Development 1996;122:1409-16.
25. Sakai H, Eishi Y, Li XL, et al. PDX-1 homeobox protein expression in pseudopyloric glands and gastric carcinomas. Gut 2004;53:323-30.
26. Miyatsuka T, Kaneto H, Shiraiwa T, et al. Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation. Genes Dev 2006;20:1435-40.
27. Fukuda A, Kawaguchi Y, Furuyama K, et al. Loss of the major duodenal papilla results in brown pigment biliary stone formation in pdx-1 null mice. Gastroenterology 2006;130:855-67.
28. Song SY, Gannon M, Washington MK, et al. Expansion of Pdx- 1-expressing pancreatic epithelium and islet neogenesis in transgenic mice overexpressing transforming growth factor alpha. Gastroenterology 1999;117:1416-26.
29. Koizumi M, Doi R, Toyoda E, et al. Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer. Surgery 2003;134:260-6.
30. Jensen JN, Cameron E, Garay MV, et al. Recapitulation of elements of embryonic development in adult mouse pancreatic regeneration. Gastroenterology 2005;128:728-41.
31. Spence JR, Lange AW, Lin SC, et al. Sox17 regulates organ lineage segregation of ventral foregut progenitor cells. Dev Cell 2009;17:62-74.
32. Jung J, Zheng M, Goldfarb M, et al. Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science 1999;284:1998-2003.
33. Gualdi R, Bossard P, Zheng M, et al. Hepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control. Genes Dev 1996;10:1670-82.
34. Angelo JR, Guerrero-Zayas MI, Tremblay KD. A fate map of the murine pancreas buds reveals a multipotent ventral foregut organ progenitor. PLoS One 2007;7:e40707.
35. Thomas IH, Saini NK, Adhikari A, et al. Neonatal diabetes mellitus with pancreatic agenesis in an infant with homozygous IPF-1 Pro63fsX60 mutation. Pediatr Diabetes 2009;10:492-6.
36. Macfarlane WM, Frayling TM, Ellard S, et al. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J Clin Invest 1999;104:R33-R9.
37. Yuan H, Li J, Xin N, et al. Expression of Pdx-1 mediates differentiation from mesenchymal stem cells into insulin-producing cells. Mol Biol Rep 2010;37:4023-31.
38. Hur J, Yang JM, Choi JI, et al. New method to differentiate human peripheral blood monocytes into insulin producing cells: human hematosphere culture. Biochem Biophys Res Commun 2012;418:765-9.
39. Al-Quobaili F, Montenarh M. Pancreatic duodenal homeobox factor-1 and diabetes mellitus type 2 (review). Int J Mol Med 2008;21:399-404.
40. Wu J, Liu S, Yu J, et al. Vertically integrated translational studies of PDX-1 as a therapeutic target for pancreatic cancer via a novel bifunctional RNAi platform. Cancer Gene Ther 2014;21:48-53.
41. Liu SH, Patel S, Gingras MC, et al. PDX-1: demonstration of oncogenic properties in pancreatic cancer. Cancer 2011;117:723-33.
42. Liu SH, Rao DD, Nemunaitis J, et al. PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform. PLoS One 2012;7:e40452.
43. Buettner M, Dimmler A, Magener A, et al. Gastric PDX-1 expression in pancreatic metaplasia and endocrine cell hyperplasia in atrophic corpus gastritis. Mod Pathol 2004;17:56-61.
44. Leys CM, Nomura S, Rudzinski E, et al. Expression of Pdx-1 in human gastric metaplasia and gastric adenocarcinoma. Hum Pathol 2006;37:1162-8.
45. Park JY, Hong SM, Klimstra DS, et al. Pdx-1 expression in pancreatic precursor lesions and neoplasms. Appl Immunohistochem Mol Morphol 2011;19:444-9.
46. Ballian N, Liu SH, Brunicardi FC. Transcription factor PDX-1 in human colorectal adenocarcinoma: a potential tumor marker? World J Gastroenterol 2008;14:5823-6.
47. Srivastava A, Hornick JL. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors. Am J Surg Pathol 2009;33:626-32.
48. Chan ES, Alexander J, Swanson PE, et al. PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms. Am J Surg Pathol 2012;36:737-43.
49. Munari E, Rinaldi M, Ambrosetti A, et al. Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma. Virchows Arch 2012;461:677-85.
50. Chan ES, Alexander J, Swanson PE, et al. PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms. Am J Surg Pathol 2012;36:737-43.